Ibrahim Halil Sahin Assistant Professor of Medicine Division of Hematology/Oncology at University of Pittsburgh School of Medicine, shared a post on X:
“I discussed the findings of neoadjuvant rectal cancer study of Dostarlimab with Alison Kanski Precision Oncology News!
Immunotherapy has revolutionized the management of patients with MSI-H CRC and will continue to do so!”
Source: Ibrahim Halil Sahin/X